IP Library Granted Patent US 7,118,568
Granted Patent B2
US 7,118,568 · App. 10/401,798 · Granted Oct 10, 2006

Process and device for the treatment of atrial arrhythmia

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,118,568
App. No.
10/401,798
Granted
Oct 10, 2006
Kind
B2
Abstract

A process for preventing atrial premature contractions originating within a pulmonary vein from being conducted into the left atrium of a human heart. More specifically, an ablation lesion is formed which electrically isolates the located source of the atrial premature contraction in the pulmonary vein from connection with the left atrium and blocks passage of the atrial premature contraction originating from the located source. In one embodiment, the steps of the process include advancing a medical device into the left atrium of a human heart, introducing the advanced medical device into the pulmonary vein from the left atrium of a human heart, sensing electrical activity within the pulmonary vein using the introduced medical device, locating a source of the atrial premature contraction within the pulmonary vein using the sensed electrical activity, and forming an ablation lesion in tissue of the pulmonary vein at a location proximal from the located source of the atrial premature contraction within the pulmonary vein. Conductive media and various medical devices may be used with the process.

Claims (49)

1. A process for preventing atrial premature contractions originating within a pulmonary vein from being conducted into a left atrium of a human heart comprising:

advancing a medical device into the left atrium of a human heart;

introducing the advanced medical device into the pulmonary vein from the left atrium of a human heart;

sensing electrical activity within the pulmonary vein using the introduced medical device;

locating a source of an atrial premature contraction within the pulmonary vein using the sensed electrical activity;

introducing a conductive media; and

forming a circumferential ablation lesion in tissue of the pulmonary vein at a location proximal from the located source of an atrial premature contraction within the pulmonary vein, wherein the ablation lesion electrically isolates the located source of an atrial premature contraction in the pulmonary vein from connection with the left atrium and blocks passage of an atrial premature contraction originating from the located source.

2. The process of claim 1 wherein the advanced medical device comprises a catheter.

3. The process of claim 1 wherein the introduced medical device comprises an ablation catheter and wherein the ablation catheter is used in the step of forming an ablation lesion.

4. The process of claim 1 further comprising a step of introducing an ablation member into the pulmonary vein, wherein the ablation member is used in the step of forming an ablation lesion.

5. The process of claim 1 further comprising a step of positioning an electrode within the pulmonary vein and wherein the electrode is used in the step of forming an ablation lesion.

6. The process of claim 1 further comprising a step of positioning an RF electrode within the pulmonary vein, wherein the RF electrode is used in the step of forming an ablation lesion.

7. The process of claim 1 wherein the step of forming an ablation lesion comprises using energy.

8. The process of claim 1 wherein the step of forming an ablation lesion comprises using RF energy.

9. The process of claim 1 wherein the introduced medical device further comprises a lumen, wherein the lumen is used in the step of introducing a conductive media.

10. The process of claim 1 further comprising a step of positioning the introduced medical device proximal the located source of an atrial premature contraction.

11. The process of claim 1 wherein the medical device comprises an ablation member, the process further comprising a step of positioning the ablation member proximal the located source of an atrial premature contraction after the medical device as been introduced into the pulmonary vein.

12. A process for the ablation of tissue contained within a pulmonary vein of a human heart comprising:

advancing a catheter through the atrium of the heart to the pulmonary vein;

introducing an RF electrode associated with the catheter into the pulmonary vein;

introducing a conductive media in the pulmonary vein;

applying RF energy to the RF electrode; and

creating a circumferential ablation lesion within the pulmonary vein by conducting energy from the RF electrode to the pulmonary vein tissue through the introduced conductive media, wherein the ablation lesion electrically isolates atrial premature contractions in the pulmonary vein.

13. The process of claim 12 wherein the introducing a conductive media step introduces a continuous flow of conductive media during the applying of the RF energy step.

14. The process of claim 12 wherein the introducing a conductive media step introduces the conductive media through a lumen.

15. The process of claim 12 further comprising a step of sensing electrical activity in the pulmonary vein.

16. The process of claim 15 further comprising locating a source of atrial premature contraction within the pulmonary vein using the sensed electrical activity.

17. The process of claim 16 wherein the creating an ablation lesion step creates the ablation lesion proximal the located source of atrial premature contraction.

18. The process of claim 16 wherein introducing a conductive media step introduces the conductive media at a location proximal the located source of atrial premature contraction.

19. The process of claim 6 further comprising conducting RF energy from an RF electrode to the tissue of the pulmonary vein via the conductive media.

20. A process for preventing atrial premature contractions originating within a pulmonary vein from being conducted into a left atrium of a human heart comprising:

advancing a medical device into the left atrium of a human heart;

introducing the advanced medical device into the pulmonary vein from the left atrium of a human heart;

sensing electrical activity within the pulmonary vein using the introduced medical device;

locating a source of an atrial premature contraction within the pulmonary vein using the sensed electrical activity;

expanding a surface into contact with the tissue of the pulmonary veins introducing a conductive media; and

forming an ablation lesion in tissue of the pulmonary vein at a location proximal from the located source of an atrial premature contraction within the pulmonary vein, wherein the ablation lesion electrically isolates the located source of an atrial premature contraction in the pulmonary vein from connection with the left atrium and blocks passage of an atrial premature contraction originating from the located source.

21. The process of claim 20 , wherein the conductive media passes through the surface to contact the tissue of the pulmonary vein.

22. The process of claim 20 , wherein the surface is expanded via a balloon contained within the surface.

23. A process for the ablation of tissue contained within a pulmonary vein of a human heart comprising:

advancing a catheter through the atrium of the heart to the pulmonary vein;

introducing an RF electrode associated with the catheter into the pulmonary vein;

expanding a surface associated with the catheter into contact with the tissue of the pulmonary vein;

introducing a conductive media in the pulmonary vein;

applying RF energy to the RF electrode; and

creating an ablation lesion within the pulmonary vein by conducting energy from the RF electrode to the pulmonary vein tissue through the introduced conductive media, wherein the ablation lesion electrically isolates atrial premature contractions in the pulmonary vein.

24. The process of claim 23 wherein the surface is positioned between the RF electrode and the tissue of the pulmonary vein.

25. The process of claim 24 wherein the conductive media passes through the surface.

26. The process of claim 23 wherein the surface is expanded via a balloon located within the surface.

Assignments (3)
CHANGE OF NAME Recorded Aug 10, 2006
From: ST. JUDE MEDICAL, DAIG DIVISION, INC.
To: ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC.
Reel/Frame 018082/0916 →
CHANGE OF NAME Recorded Jun 16, 2005
From: DAIG CORPORATION
To: ST. JUDE MEDICAL, DAIG DIVISION, INC.
Reel/Frame 016345/0067 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2005
From: HASSETT, JAMES A.; SWARTZ, JOHN F.; BEDNAREK, MICHAEL C.
To: DAIG CORPORATION
Reel/Frame 015841/0027 →